GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 63 filers reported holding GAMIDA CELL LTD in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $17,000 | – | 10,424 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 107,000 | $9,985,000 | 2.25% |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 175,000 | $721,000 | 0.56% |
| Rock Springs Capital Management LP | 2,154,300 | $8,940,000 | 0.22% |
| Laird Norton Wetherby Trust Company, LLC | 529,103 | $2,195,000 | 0.20% |
| Platform Technology Partners | 55,625 | $231,000 | 0.11% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,000,000 | $4,150,000 | 0.10% |
| Guild Investment Management, Inc. | 18,000 | $75,000 | 0.08% |
| FEDERATED HERMES, INC. | 5,128,300 | $21,282,000 | 0.05% |
| MEITAV INVESTMENT HOUSE LTD | 429,352 | $1,782,000 | 0.03% |
| 1492 Capital Management LLC | 10,000 | $42,000 | 0.02% |